1. Guidance on the non-clinical investigation of the dependence potential of medicinal products,2006
2. Guidance document on the clinical assessment of abuse liability for drugs with central nervous system activity,2007
3. Guidance for industry on the assessment of abuse potential of drugs,2010
4. Guidelines and methodological reviews concerning drug abuse liability assessment;Balster;Drug Alcohol Depend,2003
5. Guidance for industry on the safety testing of metabolites,2008